Is St. Jude losing the CRM battle to Boston Scientific and Medtronic?
January 28, 2010 by MedCity News
St. Jude Medical Inc. blames lower hospital spending for a drop in sales of its pacemakers and defibrillators. There's only one problem: Its main competitors, Boston Scientific Corp. and Medtronic Inc., aren't seeing the same decline.
By Thomas Lee
LITTLE CANADA, Minnesota - It’s no secret that pacemakers and defibrillators are no longer a hot growth market. Most estimates peg global sales at growing low to mid single digits for the foreseeable future.
But for St. Jude Medical Inc, (NYSE:STJ) the question remains: How much is the company to blame for its lackluster U.S. numbers?
Business/Financial News, News Well, MassDevice.com Earnings Roundup, Cardiac Rhythm Management, Cardiovascular, Q4
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
- Physician blogger insights on social media
Navigation
NEWS
GE Healthcare unveils soft tissue imaging technology
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint...
Hip implants: Johnson & Johnson's DePuy will stop selling metal-on-metal implants
Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-...
Combat Medical Systems wins 1st-of-its kind approval for tourniquet
The FDA approves a novel combat-ready clamp to treat wounds most commonly associated with roadside or...
Vascular Solutions CEO: Boston Scientific's alleged patent infringement 'blatant'
Vascular Solutions CEO Howard Root says alleged infringement by Boston Scientific's Guidezilla "is...
Globus Medical sues J&J's DePuy Synthes unit over spine implant patent
Globus Medical accuses Johnson & Johnson's DePuy Synthes unit of violating its patent for an...
